SciELO - Scientific Electronic Library Online

 
vol.19 issue6Adenosine-induced transient atrial fibrillation in a patient with atrial tachycardiaParaquat intoxications and hemoperfusion with activated charcoal author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Anales de Medicina Interna

Print version ISSN 0212-7199

Abstract

PORCAR RAMELLS, C. et al. Primary cardiac lymphoma: antemortem cytologic diagnosis and treatment with a response to polychemotherapy and the autologous peripheral blood stem cells transplantation. Presentation of one case report and review of the literature. An. Med. Interna (Madrid) [online]. 2002, vol.19, n.6, pp.45-51. ISSN 0212-7199.

The primary cardiac lymphoma (PCL) is an extremely infrequent tumor suffered by immunocompetents patients with a difficult diagnosis and slow progress leading to a serious prognosis and few therapeutically possibilities. It's a primary-cardiac non-Hodgkin's lymphoma (NHL) in a patient of 46-year-old, immunocompetent, who started with a congestive heart failure and atrial flutter. Some examinations were carried out such as a transesophageal echocardiography (TEE), a computed tomography (TC) and a magnetic resonance imaging (MRI) and an intracardiac tumor placed in the interauricular septum was detected. The diagnosis was based on a pleural fluid cytological examination. It was decided to follow a chemotherapy treatment and the autologous peripheral blood stem cells transplantation was carried out. The patient remains in full remission thirty-six months after diagnosis and twenty-nine months after the autotransplant. Our clinical experience indicated that an early and accurate diagnosis combined with the appropriate and aggressive antilymphoma therapy can thus help in obtaining a long survival in patients with PCL.

Keywords : Primary cardiac lymphoma; Diagnosis; Prognosis; Treatment.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License